Swiss National Bank Mirati Therapeutics, Inc. Transaction History

Swiss National Bank

$140 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$41.99 - $62.38 $1.21 Million - $1.8 Million	-28,800 Reduced 25.76%	83,000 $4.88 Million
Q3 2023 Nov 08, 2023	BUY	$27.8 - $45.35 $644,960 - $1.05 Million	23,200 Added 26.19%	111,800 $4.87 Million
Q2 2023 Aug 09, 2023	BUY	$36.13 - $49.49 $57,808 - $79,184	1,600 Added 1.84%	88,600 $3.2 Million
Q1 2023 May 10, 2023	SELL	$36.54 - $54.26 $255,780 - $379,820	-7,000 Reduced 7.45%	87,000 $3.23 Million
Q4 2022 Feb 08, 2023	BUY	$41.27 - $98.62 $74,286 - $177,516	1,800 Added 1.95%	94,000 $4.26 Million

Q3 2022 Nov 09, 2022	BUY	$59.5 - $86.7 $53,550 - $78,030	900 Added 0.99%	92,200 $6.44 Million
Q1 2022 May 09, 2022	BUY	$75.82 - $150.97 $894,675 - $1.78 Million	11,800 Added 14.84%	91,300 $7.51 Million
Q4 2021 Feb 08, 2022	SELL	$132.01 - $190.29 $13,201 - $19,029	-100 Reduced 0.13%	79,500 $11.7 Million
Q3 2021 Nov 08, 2021	BUY	$132.13 - $177.45 $198,195 - $266,175	1,500 Added 1.92%	79,600 $14.1 Million
Q2 2021 Aug 06, 2021	SELL	$144.0 - $179.73 $331,200 - $413,379	-2,300 Reduced 2.86%	78,100 $12.6 Million
Q1 2021 May 07, 2021	BUY	$158.92 - $221.61 $2.37 Million - $3.3 Million	14,900 Added 22.75%	80,400 $13.8 Million
Q4 2020 Feb 05, 2021	BUY	$162.05 - $240.27 $194,460 - $288,324	1,200 Added 1.87%	65,500 $14.4 Million
Q3 2020 Nov 09, 2020	BUY	$113.26 - $167.27 $135,912 - $200,724	1,200 Added 1.9%	64,300 $10.7 Million
Q2 2020 Aug 05, 2020	BUY	$72.01 - $120.39 $964,934 - $1.61 Million	13,400 Added 26.96%	63,100 $7.2 Million
Q1 2020 May 08, 2020	BUY	$69.78 - $116.21 $55,824 - $92,968	800 Added 1.64%	49,700 $3.82 Million
Q4 2019 Feb 06, 2020	BUY	$70.76 - $128.86 $353,800 - $644,300	5,000 Added 11.39%	48,900 $6.3 Million
Q3 2019 Nov 12, 2019	BUY	$77.91 - $109.6 $93,492 - $131,520	1,200 Added 2.81%	43,900 $3.42 Million
Q2 2019 Aug 02, 2019	BUY	$59.49 - $104.71 $422,379 - $743,441	7,100 Added 19.94%	42,700 $4.4 Million
Q1 2019 May 10, 2019	BUY	$43.65 - $78.95 $56,745 - $102,635	1,300 Added 3.79%	35,600 $2.61 Million
Q4 2018 Feb 13, 2019	BUY	$32.0 - $47.43 $128,000 - $189,720	4,000 Added 13.2%	34,300 $1.46 Million
Q2 2018 Aug 09, 2018	BUY	$26.05 - $52.4 $789,315 - $1.59 Million	30,300 New	30,300 $1.49 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account